As the latest issues of MEDICC Review reveal, the global scientific community is fully engaged in unraveling the mysteries of COVID-19, including its relationship to chronic conditions such as diabetes mellitus (DM), a frequent comorbidity with SARSCoV-2 infection. Various studies report up to 30% of persons with COVID-19 are diabetic,[1] and such patients are at greater risk of intrahospital deaths from the disease.[2] Huang’s meta-analysis in China reviewed 30 studies assessing 6452 cases showed that DM patients had worse prognosis (RR 2.38 [CI 95%: 1.88–3.03; p 65 years also had greater risk of dying from COVID-19.
展开▼
机译：作为MEDICC审查的最新问题，全球科学界完全从事Covid-19的奥秘，包括其与糖尿病（DM）等慢性病症的关系，频繁使用SARSCOV-2感染。各种研究报告高达30％的Covid-19患有糖尿病，[1]，此类患者对疾病的境内死亡的风险更大。[2]中国的荟萃分析回顾了30项评估6452例，表明DM患者预后差（RR 2.38 [CI 95％：1.88-3.03; P 65岁也有更大的从Covid-19死亡风险。
展开▼
